| |
|
Form Serial Number: |
DA20240205E00128
|
| 1.
Date of relevant event: |
31/01/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02480 |
| 4.
Name of listed corporation: |
Beijing Luzhu Biotechnology Co., Ltd. - B - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
202,449,032 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Ma |
| (Other names) |
Biao |
|
|
|
| 10.
Name of director (Chinese): |
马骉 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
51,721,196 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 51,721,196 | 36.24 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 51,721,196 | 25.55 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2201 | Interest of corporation controlled by you |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 北京亦庄生物医药并购投资中心（有限合伙） | 北京市北京经济技术开发区兴盛街8号1号楼104室 | 北京屹唐賽盈基金管理有限公司 | 1.25 | Y | |
| 北京亦庄二期生物医药产业投资基金（有限合伙） | 北京市北京经济技术开发区兴盛街8号1号楼102室 | 北京屹唐賽盈基金管理有限公司 | 1.00 | Y | |
| 北京屹唐賽盈基金管理有限公司 | 北京市北京经济技术开发区兴盛街8号1号楼105室 | 天津赛鼎方德资产管理中心 | 34.00 | N | |
| 天津赛鼎方德资产管理中心 | Room 5169, fifth floor, building 3, Tianrui Road, Wuqing District Automobile Industry Park, Tianjin, China | Ma Biao | 60.00 | N | |
| 北京赛升药业股份有限公司 | No.8 Xingsheng Street Eco&Tech Zone,Beijing,China | Ma Biao | 49.51 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Beijing Luzhu Biotechnology Co., Ltd. (the "Company") has completed the H share full circulation on Jan 31, 2024 where an aggregate of 59,729,296 unlisted shares of the Company have been converted to H shares. So, the total number of issued H shares has been increased with the shareholding ratio of H shares owned by Mr. Ma diluted and decreased. Please refer to the announcements of the Company dated Dec 28, 2023, Jan 17, 29 and 31, 2024 for details.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
05/02/2024
(dd/mm/yyyy)
|
| |